Voyager Therapeutics has hit pause on a preclinical Alzheimer’s disease program just eight months after unveiling the asset. The neurology biotech announced back in July 2025 that it was adding a new ...
LEXINGTON, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...
SMBs have the same intelligence needs as enterprises. They need clarity, speed, and confidence in their data. The Voyager program and Mission Control Network allows us to deliver those capabilities.” ...
Breaking the AI Hardware Barrier: Enterprise-Grade Intelligence for Every Business—Starting with the MSPs Who Serve Them SMBs have the same intelligence needs as enterprises. They need clarity, speed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results